Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Conceptus

This article was originally published in The Gray Sheet

Executive Summary

Conceptus: ERA resectoscope sheath gets marketing go ahead from FDA for use in gynecological applications including endometrial resection and ablation, myomectomy (fibroid removal) and polypectomy. The single-use device is intended for use with existing electrosurgical systems "to enhance the safety of therapeutic hysteroscopy procedures," Conceptus states. Company President and CEO Kathryn Tunstall commented: "By enhancing the safety of therapeutic hysteroscopy procedures, and making the procedures less costly and less burdensome for the OR staff, we believe that ERA will encourage the adoption of therapeutic hysteroscopy as a viable, minimally invasive alternative" to hysterectomy...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel